Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 5,149-5,160 of 10,592
Drug study icon
CompletedNCT01259492

Methylphenidate Hydrochloride Extended Release for ADHD

This study is completed in the United States, in Belgium, in Colombia, .... It is testing methylphenidate Hydrochloride Extended Release for ADHD.

In United States
ADHDDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States, Belgium, Colombia, ...
Sponsor
Novartis Pharmaceuticals
Condition
ADHD
Behavioral study icon
TerminatedNCT01842542

NeuroStar TMS Therapy for depression

This study was terminated in the United States. It is testing NeuroStar TMS Therapy for depression.

In United States
DepressionBehavioralFrom 18 Years to 50 Years
Countries
United States
Sponsor
Neuronetics
Condition
Depression
Drug study icon
CompletedNCT00709202

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

This study exists to see whether the medication Betahistine can play a useful role in care. Researchers are trying to understand what the medication Betahistine could change in day-to-day care and decision-making.

In United States
Bipolarity, SchizophreniaDrugFrom 18 Years to 59 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Bipolarity, Schizophrenia
Behavioral study icon
TerminatedNCT05541406

Efficacy of a Multi-level School Intervention for LGBTQ Youth

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Suicidality, PTSD, ...BehavioralFrom 12 Years to 20 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Suicidality, PTSD, ...
Behavioral study icon
CompletedNCT02150668

Efficacy of an Organizational Skills Intervention for Middle School Students With ADHD

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In United States
ADHDBehavioralFrom 11 Years to 15 Years
Countries
United States
Sponsor
Virginia Commonwealth University
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.